To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin

References

• Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. (2005). Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm, 293:145–153.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. (1971). Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 60:1281–1302.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Nakamura A. (1965). A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: Dispersion of Β-carotene by polyvinylpyrrolidone. Kolloid-Z Polym, 203:130–133.
   Web of Science ®Google Scholar
• Sekikawa H, Fukuda N, Takada M, Ohtani K, Arita T, Nakano M. (1983). Dissolution behavior and gastrointestinal absorption of dicumarol from solid dispersion systems of dicumarol-polyvinylpyrrolidone and dicumarol-β-cyclodextrin. Chem Pharm Bull, 31:1350–1356.
   PubMed Web of Science ®Google Scholar
• Ford JL. (1986). The current status of solid dispersions. Pharm Acta Helv, 61:69–88.
   PubMedGoogle Scholar
• Sekikawa H, Nakano M, Arita T. (1978). Inhibitory Effect of Polyvinylpyrrolidone on the crystallization of drugs. Chem Pharm Bull, 26:118–126.
   Web of Science ®Google Scholar
• Yoshioka M, Hancock BC, Zografi G. (1995). Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J Pharm Sci, 84:983–986.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691–1698.
   PubMed Web of Science ®Google Scholar
• Mura P, Moyano JR, González-Rodríguez ML, Rabasco-Alvaréz AM, Cirri M, Maestrelli F. (2005). Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev Ind Pharm, 31:425–434.
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Feldman S, Wynn R, Weiner ND. (1968). Dissolution rates in surfactant solutions under stirred and static conditions. J Pharm Sci, 57:787–791.
   PubMed Web of Science ®Google Scholar
• Singh P, Desai SJ, Flanagan DR, Simonelli AP, Higuchi WI. (1968). Mechanistic study of the influence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs. J Pharm Sci, 57:959–965.
   PubMed Web of Science ®Google Scholar
• Corrigan OI. (1985). Mechanism of dissolution of fast release solid dispersions. Drug Dev Ind Pharm, 11:697–724.
   Web of Science ®Google Scholar
• Fernandez J, Vila-Jato JL, Blanco J, Ford LJ. (1989). Some properties of Diazepam-polyethylene glycol 6000 solid dispersions and their modification in the presence of stearic acid and polysorbate 80. Drug Dev Ind Pharm, 15:2491–2513.
   Web of Science ®Google Scholar
• Sjkovist E, Nystrom C. (1988). Physicochemical aspects of drug release VI. Drug dissolution rate from solid particulate dispersions and the importance of carrier and drug particle properties. Int J Pharm, 47:51–66.
   Web of Science ®Google Scholar
• Sjkovist E, Nystrom C, Alden M. (1991). Physicochemical aspects of drug release XIII. The effect of sodium dodecyl sulfate additions on the structure and dissolution of a drug in solid dispersions. Int J Pharm, 69:53–62.
   Web of Science ®Google Scholar
• Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 29:278–287.
   PubMed Web of Science ®Google Scholar
• Sjkovist E, Nystrom C, Alden M, Caram-Lehlam N. (1992). Physicochemical aspects of drug release. XIV. The effects of some ionic and non ionic surfactants on properties of a sparingly soluble drug in solid dispersions. Int J Pharm, 79:123–133.
   Web of Science ®Google Scholar
• Wang X, Michoel A, Van den Mooter G. (2005). Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm, 303:54–61.
   PubMed Web of Science ®Google Scholar
• Ismail S, Shawky S, Hafez E. (1987). A new approach for enhancing the dissolution rate of Phenacetin. Drug Dev Ind Pharm, 13:2147–2158.
   Web of Science ®Google Scholar
• Mallick S, Pattnaik S, Swain K, De PK. (2007). Current perspectives of solubilization: potential for improved bioavailability. Drug Dev Ind Pharm, 33:865–873.
   PubMed Web of Science ®Google Scholar
• Nasr HE, Gaffar MS, Abdel-Kareem O, Abd El-Aziz F. (2010). Morphological, Rheological and Ultrasonic Characterizations of ECO-Friendly Microemulsion Lattices Based on Acrylate Monomers. J Am Sci, 6:897–910.
   Google Scholar
• Sammour OA, Hammad MA, Zidan AS, Mowafy AG. (2011). QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion. Pharm Dev Technol, 16:219–227.
   PubMed Web of Science ®Google Scholar
• Emara LH, Badr RM, Elbary AA. (2002). Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers. Drug Dev Ind Pharm, 28:795–807.
   PubMed Web of Science ®Google Scholar
• Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D et al. (2004). Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm, 30:303–317.
   PubMed Web of Science ®Google Scholar
• Karnachi A, De Hon R, Khan M. (1995). Compression of indomethacin coprecipitates with polymer mixtures: Effect of preparation methodology. Drug Dev Ind Pharm, 21:1473–1483.
   Web of Science ®Google Scholar
• Fini A, Cavallari C, Ospitali F. (2008). Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Eur J Pharm Biopharm, 70:409–420.
   PubMed Web of Science ®Google Scholar
• van Drooge DJ, Hinrichs WL, Frijlink HW. (2004). Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J Control Release, 97:441–452.
   PubMed Web of Science ®Google Scholar
• de Waard H, Hinrichs WL, Visser MR, Bologna C, Frijlink HW. (2008). Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm, 349:66–73.
   PubMed Web of Science ®Google Scholar
• Okonogi S, Puttipipatkhachorn S. (2006). Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech, 7:E52.
   PubMedGoogle Scholar
• Cheng Y, Ye X, Huang XD, Ma HR. (2006). Reentrant wetting transition on surfactant solution surfaces. J Chem Phys, 125:164709.
   PubMed Web of Science ®Google Scholar
• Bonnefond A, Paulis M, Leiza JR (2011). Kinetics of the emulsion copolymerization of MMA/BA in the presence of sodium montmorillonite. Appl Clay Sci, 51:110–116.
   Web of Science ®Google Scholar